Antiangiogenesis Therapy of Endometriosis Using PAMAM as a Gene Vector in a Noninvasive Animal Model

Figure 7

CD31 and VEGF expression in endometrial lesions in nude mice (400x, Bar=100 μm) (a–e): CD31 expression in microvessels in the implanting lesions ((a) HD Pamam-Es; (b) LD PAMAM-Es; (c) Lipofectamine-Es; (d) PAMAM; (e) PBS); (f–j): VEGF expression in cells of the implanting lesions ((f) HD Pamam-Es; (g) LD PAMAM-Es; (h) Lipofectamine-Es; (i) PAMAM; (j) PBS).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)